Your browser doesn't support javascript.
loading
The human melanoma proteome atlas-Defining the molecular pathology.
Betancourt, Lazaro Hiram; Gil, Jeovanis; Kim, Yonghyo; Doma, Viktória; Çakir, Ugur; Sanchez, Aniel; Murillo, Jimmy Rodriguez; Kuras, Magdalena; Parada, Indira Pla; Sugihara, Yutaka; Appelqvist, Roger; Wieslander, Elisabet; Welinder, Charlotte; Velasquez, Erika; de Almeida, Natália Pinto; Woldmar, Nicole; Marko-Varga, Matilda; Pawlowski, Krzysztof; Eriksson, Jonatan; Szeitz, Beáta; Baldetorp, Bo; Ingvar, Christian; Olsson, Håkan; Lundgren, Lotta; Lindberg, Henrik; Oskolas, Henriett; Lee, Boram; Berge, Ethan; Sjögren, Marie; Eriksson, Carina; Kim, Dasol; Kwon, Ho Jeong; Knudsen, Beatrice; Rezeli, Melinda; Hong, Runyu; Horvatovich, Peter; Miliotis, Tasso; Nishimura, Toshihide; Kato, Harubumi; Steinfelder, Erik; Oppermann, Madalina; Miller, Ken; Florindi, Francesco; Zhou, Qimin; Domont, Gilberto B; Pizzatti, Luciana; Nogueira, Fábio C S; Horvath, Peter; Szadai, Leticia; Tímár, József.
  • Betancourt LH; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Gil J; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Kim Y; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Doma V; Department of Pathology, Semmelweis University, Hungary.
  • Çakir U; Department of Dermatology, Venerology and Dermatooncology, Semmelweis University, Budapest, Hungary.
  • Sanchez A; Department of Dermatology, Venerology and Dermatooncology, Semmelweis University, Budapest, Hungary.
  • Murillo JR; Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Kuras M; Department of Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
  • Parada IP; Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Sugihara Y; Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Appelqvist R; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Wieslander E; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Welinder C; Clinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lerund University, Lund, Sweden.
  • Velasquez E; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • de Almeida NP; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Woldmar N; Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Marko-Varga M; Clinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lerund University, Lund, Sweden.
  • Pawlowski K; Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Eriksson J; Clinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lerund University, Lund, Sweden.
  • Szeitz B; Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
  • Baldetorp B; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Ingvar C; Section for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
  • Olsson H; Department of Molecular Biology, University of Texas Southwestern Medical Center, Texas, USA.
  • Lundgren L; Department of Biochemistry and Microbiology, Warsaw University of Life Sciences, Warszawa, Poland.
  • Lindberg H; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Oskolas H; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.
  • Lee B; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Berge E; SUS University Hospital Lund, Lund, Sweden.
  • Sjögren M; Department of Surgery, Clinical Sciences, Lund University, SUS, Lund, Sweden.
  • Eriksson C; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Kim D; SUS University Hospital Lund, Lund, Sweden.
  • Kwon HJ; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Knudsen B; SUS University Hospital Lund, Lund, Sweden.
  • Rezeli M; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Hong R; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Horvatovich P; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Miliotis T; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Nishimura T; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Kato H; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
  • Steinfelder E; Chemical Genomics Global Research Lab, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea.
  • Oppermann M; Chemical Genomics Global Research Lab, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea.
  • Miller K; Department of Pathology, University of Utah, Salt Lake City, USA.
  • Florindi F; Clinical Protein Science & Imaging, Biomedical Centre, Department of Biomedical Engineering, Lerund University, Lund, Sweden.
  • Zhou Q; Department of Biochemistry and Molecular Pharmacology, Institute for Systems Genetics, New York University Grossman School of Medicine, New York, USA.
  • Domont GB; Department of Analytical Biochemistry, Faculty of Science and Engineering, University of Groningen, Groningen, The Netherlands.
  • Pizzatti L; Translational Science and Experimental Medicine, Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Nogueira FCS; Department of Oncology, St. Marianna University School of Medicine, Kanagawa, Japan.
  • Horvath P; Department of Surgery, Tokyo Medical University, Tokyo, Japan.
  • Szadai L; ThermoFisher Scientific, HQ, San Jose, California, USA.
  • Tímár J; ThermoFisher Scientific, HQ, San Jose, California, USA.
Clin Transl Med ; 11(7): e473, 2021 07.
Article en En | MEDLINE | ID: mdl-34323403
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Proteoma / Proteómica / Melanoma Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Proteoma / Proteómica / Melanoma Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article